Komori
Alfresa Holdings (2784) · FactFirst stated

FY2019 Q1: Higher Revenue and Profit in the Wholesale Business for Prescription Pharmaceuticals and Other Products

First written in FY2019-Q1. . Latest entry: FY2019-Q1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Revenue and profit growth in the wholesale business for prescription pharmaceuticals and other productsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2019-Q1First statedAnnual report

    「これらの結果、当セグメントの当第１四半期連結累計期間の業績は、売上高5,842億67百万円（前年同期比2.9％増）、営業利益90億64百万円（同92.0％増）となりました。」

    医療用医薬品等卸売事業は増収増益となり、営業利益は前年同期比92.0％増となった。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.